It is now time to recommend that Meridian Biosciences (VIVO) be sold at the market. The stock has performed reasonably since the research recommendation was issued on March 26, 2009. It is highly recommended that anyone who bought the stock based on my research should re-read the posting. The stock initially went down, but once the reporting of the swine flu came out the stock recovered all the losses and then started going higher. From the current level VIVO is poised to reach the $23.33 with little effort. However, the returns that this stock has provided within the last seventy-eight (78) days say that it is worthwhile considering alternatives.
VIVO was recommended when it was trading at $18.21. As of Friday June 12, 2009, VIVO was quoted at $20.35. This equals a return of 11.75% in almost 3 months. Conservatively, on an annualized basis this would equal approximately 54% return. Selling this stock now also generates a return 286% greater than the amount of the dividend yield if the stock was held for a whole year.
It is always recommended that when selling a stock, one should not place an order after hours or when the market is closed. This leaves the seller in the position of being vulnerable to the whims of the market makers. Instead, place your sell orders only as a market order during market hours. Some would complain that a market order during market hours might leave some profits on the table. However, I would rather leave some money on the table rather than have it taken away from me by the trades that are placed by institutions and market makers. Touc.
No comments:
Post a Comment